Unexpected high frequency of P46L TNFRSF1A allele in sub-Saharan West African populations
- 8 December 2004
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 13 (4) , 513-515
- https://doi.org/10.1038/sj.ejhg.5201344
Abstract
TNF receptor-associated periodic syndrome (TRAPS) is an autosomal dominant disorder characterized by recurrent attacks of fever and serositis. To date, more than 30 mutations have been reported in TNFRSF1A, the responsible gene. In Caucasian populations, the P46L (c.224C>T) TNFRSF1A sequence variation is considered as a low-penetrance mutation because its allele frequency is similar in patients and controls (1%). Whereas the spectrum of TNFRSF1A gene mutations has been well established in Caucasian and several Mediterranean populations, it remains unknown in sub-Saharan African populations. In this study, we found an unexpected high P46L allele frequency (10%) in two groups from West Africa – a group of 145 patients with sickle cell anaemia and a group of 349 healthy controls. These data suggest that the P46L variant is rather a polymorphism than a TRAPS causative mutation. We propose that the P46L high frequency in West African populations could be explained by some biological advantage conferred to carriers.Keywords
This publication has 10 references indexed in Scilit:
- Heterogeneity among patients with tumor necrosis factor receptor–associated periodic syndrome phenotypesArthritis & Rheumatism, 2003
- Genetic susceptibility to infectious diseaseTrends in Microbiology, 2003
- HUMAN GENETIC POLYMORPHISMS AND ASYMPTOMATIC PLASMODIUM FALCIPARUM MALARIA IN GABONESE SCHOOLCHILDRENThe American Journal of Tropical Medicine and Hygiene, 2003
- Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanerceptClinical and Experimental Immunology, 2002
- The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor–associated periodic syndromeArthritis & Rheumatism, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- The Tumor-Necrosis-Factor Receptor–Associated Periodic Syndrome: New Mutations in TNFRSF1A, Ancestral Origins, Genotype-Phenotype Studies, and Evidence for Further Genetic Heterogeneity of Periodic FeversAmerican Journal of Human Genetics, 2001
- A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French familyArthritis & Rheumatism, 2000
- Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory SyndromesCell, 1999
- Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenesNature, 1993